Skip to main content

Table 4 Emerging trends of originator medicines

From: Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis

 

Trend 1

Trend 2

Trend 3

Global Core

1. Ventolin®

5. Zocor

4. Capoten

2. Daonil®

7. Ciprobay

6. Tryptanol

3. Tenormin

14. Losec

9. Amoxil

8. Bactrim

  

10. Rocephin

  

11. Valium

  

12. Voltaren

  

13. Panado

  

Regional Core

16. Norvasc

25 Glucophage

15 Albendazolea

17. Lipitor

20 Renitec

18 Becotide a

21. Prozac

 

19 Keflex

26. Flagyl

 

22 Diamicron

27. Adalat Retard

 

23 Dichloride

28. Zantac

 

24 Brufen

29. Epilim

  

Supplementary

30. Zovirax

34. Diflucan

39. Crestorb

31. Tegretol

45. Lenamet

43. Erythrocin

32. Augmentin

  

33. Lanoxin

  

35. Nizoral

  

36. Cozaar

  

37. Epanutin

  

38. Rimactane

  

40. Tarivid

  

41. Aminophylline

  

42. Daktarin

  

44. Zithromax

  

46. Zestril

  

47. Clarityne

  

48. Fortum

  

49. Ismo

  

50. Eltroxin

  

30. Zovirax

  

31. Tegretol

  

32. Augmentin

  

33. Lanoxin

  

35. Nizoral

  

36. Cozaar

  

37. Epanutin

  

38. Rimactane

  

40. Tarivid

  
  1. aChange in dosage form
  2. bManufactured in 2006